Maruhashi Tatsuya, Noma Kensuke, Iwamoto Yumiko, Iwamoto Akimichi, Oda Nozomu, Kajikawa Masato, Matsumoto Takeshi, Hidaka Takayuki, Kihara Yasuki, Chayama Kazuaki, Nakashima Ayumu, Goto Chikara, Liao James K, Higashi Yukihito
Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Department of Regeneration and Medicine, Research Center for Radiation Genome Medicine, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
PLoS One. 2014 Oct 3;9(10):e109017. doi: 10.1371/journal.pone.0109017. eCollection 2014.
Rho-associated kinase (ROCK) signaling pathway has been shown to mediate various cellular functions including cell proliferation, migration, adhesion, apoptosis, and contraction, all of which may be involved in pathogenesis of atherosclerosis. Endogenous nitric oxide (NO) is well known to have an anti-atherosclerotic effect, whereas the exogenous NO-mediated cardiovascular effect still remains controversial. The purpose of this study was to evaluate the effect of exogenous NO on ROCK activity in vascular smooth muscle cells (VSMCs) in vitro and in vivo.
VSMCs migration was evaluated using a modified Boyden chamber assay. ROCK activities were measured by Western blot analysis in murine and human VSMCs and aorta of mice treated with or without angiotensin II (Ang II) and/or sodium nitroprusside (SNP), an NO donor.
Co-treatment with SNP inhibited the Ang II-induced cell migration and increases in ROCK activity in murine and human VSMCs. Similarly, the increased ROCK activity 2 weeks after Ang II infusion in the mouse aorta was substantially inhibited by subcutaneous injection of SNP.
These findings suggest that administration of exogenous NO can inhibit ROCK activity in VSMCs in vitro and in vivo.
Rho相关激酶(ROCK)信号通路已被证明可介导多种细胞功能,包括细胞增殖、迁移、黏附、凋亡和收缩,所有这些功能都可能参与动脉粥样硬化的发病机制。内源性一氧化氮(NO)具有抗动脉粥样硬化作用,而外源性NO介导的心血管效应仍存在争议。本研究的目的是评估外源性NO对体外和体内血管平滑肌细胞(VSMC)中ROCK活性的影响。
使用改良的Boyden小室试验评估VSMC迁移。通过蛋白质印迹分析测量用或不用血管紧张素II(Ang II)和/或一氧化氮供体硝普钠(SNP)处理的小鼠和人VSMC及小鼠主动脉中的ROCK活性。
SNP联合处理可抑制Ang II诱导的小鼠和人VSMC中的细胞迁移及ROCK活性增加。同样,皮下注射SNP可显著抑制小鼠主动脉在输注Ang II 2周后ROCK活性的增加。
这些发现表明,外源性NO给药可在体外和体内抑制VSMC中的ROCK活性。